Made in America, Built with China: The Hidden Component Dependency Reshoring Companies Won't Advertise
The press releases write themselves. A US manufacturer announces the closure of its Shenzhen facility, the ribbon-cutting at a Tennessee plant, the creation of hundreds of domestic jobs. Politicians applaud. Investors reward the stock. And somewhere in the fine print of the company's supplier disclosure documents, a list of Chinese component vendors stretches across several pages, largely unchanged from the year before.
This is the reshoring mirage — a structural paradox that has quietly taken hold across American industry. Companies are genuinely moving final assembly back to US soil. But the deeper architecture of their supply chains, the subcomponents, raw materials, specialty chemicals, precision electronics, and engineered polymers that feed those domestic assembly lines, remains anchored in China with remarkable consistency.
For US business professionals evaluating supply chain risk, sourcing strategy, or competitive positioning, understanding exactly where this dependency persists is not merely academic. It is operationally urgent.
The Anatomy of Incomplete Decoupling
To understand why reshoring rarely means what it implies, it helps to think in tiers. A finished product assembled in Ohio may contain dozens of subcomponents. Each of those subcomponents may in turn be built from materials, coatings, or precision parts sourced from a second-tier supplier. It is in these lower tiers — tier two, tier three, and beyond — where Chinese sourcing remains deeply entrenched, often invisible to the buyer's own procurement team.
Consider the electronics sector. A US company assembling circuit boards domestically still requires passive components: capacitors, resistors, inductors. China accounts for a dominant share of global passive component production, with manufacturers in Guangdong and Jiangsu supplying the majority of the world's volume at price points that no reshored alternative currently matches. An American assembler pulling components from a domestic distributor may not realize, or may choose not to investigate, that those components originated in Dongguan.
The same pattern appears in industrial machinery, medical devices, consumer appliances, and automotive parts. The visible layer relocates. The invisible layer stays.
Why Companies Accept the Contradiction
The persistence of Chinese component sourcing is not simply a failure of will. It reflects a set of genuine economic and logistical realities that companies navigating the reshoring conversation rarely discuss publicly.
First, there is the concentration problem. For certain categories of manufactured inputs — rare earth-derived magnets, lithium battery cells, specific semiconductor packages, and advanced display components — Chinese production represents not merely a large share of global supply but effectively the entire accessible market at commercial scale. No domestic alternative exists in sufficient volume. Sourcing elsewhere often means sourcing from a facility that itself relies on Chinese upstream inputs, a dynamic that creates the illusion of diversification without the substance.
Second, there is the cost arithmetic. Reshoring final assembly can be justified through a combination of labor savings from automation, reduced logistics complexity, proximity to customers, and the reputational value of domestic production claims. But replicating China's component manufacturing ecosystem — built over decades through coordinated industrial policy, infrastructure investment, and deep supplier clustering — is a generational undertaking, not a procurement decision. US companies making rational short-term choices will continue buying Chinese components even as they build American factories.
Third, there is the qualification burden. In regulated industries such as aerospace, pharmaceuticals, and medical devices, switching a component supplier requires extensive validation and testing cycles that can span years and cost millions. Even companies that want to reduce Chinese component exposure often cannot move quickly without risking production disruptions or regulatory complications.
Where the Vulnerabilities Actually Live
For procurement and supply chain professionals, the practical question is not whether Chinese component dependency exists — it does — but where it creates the most consequential exposure.
Geopolitical disruption represents the most acute risk. Export controls, tariff escalations, and shipping lane complications can affect specific component categories with little warning. Companies whose Chinese component dependency is concentrated in categories subject to ongoing US-China trade friction — semiconductors, certain battery technologies, telecommunications hardware — face a qualitatively different risk profile than those sourcing commodity materials.
Single-source dependency compounds the problem. A company that assembles domestically but relies on a single Chinese supplier for a critical subcomponent has, in practical terms, moved its supply chain vulnerability without reducing it. The factory is in Ohio. The chokepoint is in Shenzhen.
Quality and specification drift presents a subtler challenge. As Chinese suppliers continue advancing their own technological capabilities, the specifications of components they produce evolve. US buyers who have not maintained active supplier relationships — assuming that reshoring domestic assembly reduces the need for China engagement — may find themselves caught off guard by material changes that affect product performance.
A Framework for Honest Supply Chain Assessment
The companies navigating this landscape most effectively are those that have replaced the binary language of reshoring with a more granular, category-by-category analysis of where genuine independence is achievable and where it is not.
This begins with a full-tier supplier mapping exercise — one that goes beyond tier-one vendors to trace the origin of critical inputs at least two levels deeper. For many companies undertaking this analysis seriously for the first time, the results are revelatory. Components assumed to be domestically sourced turn out to have Chinese origins several steps back in the chain.
From that baseline, a realistic diversification strategy distinguishes between categories where alternatives exist and categories where they do not. For commodity inputs with multiple global sources, active supplier development outside China is a viable risk mitigation lever. For categories where Chinese production is dominant by a wide margin, the more honest strategy involves building inventory buffers, securing long-term supply agreements, and investing in demand forecasting that accounts for potential disruption windows.
Engagement with Chinese suppliers, rather than disengagement, often serves US companies better in this environment. Maintaining strong relationships with established Chinese component vendors provides access to allocation priority during tight markets, early visibility into specification changes, and leverage in pricing negotiations that companies who have publicly distanced themselves from Chinese sourcing often lose.
The Reputational and Strategic Calculus
There is a communications dimension to this issue that US companies would be unwise to ignore. As supply chain transparency requirements expand — driven by both regulatory pressure and investor ESG scrutiny — the gap between reshoring claims and component sourcing reality will become harder to maintain. Companies that have built marketing narratives around domestic production without disclosing persistent Chinese component dependency face growing exposure as disclosure standards tighten.
The strategic response is not to abandon reshoring initiatives, which carry genuine operational and reputational value, but to develop more honest and defensible frameworks for describing what those initiatives actually achieve. Domestic assembly with Chinese components is a legitimate and often sensible supply chain configuration. Presenting it as supply chain independence is something else entirely.
For US companies doing business with Chinese suppliers — whether as buyers of finished goods, component importers, or participants in joint manufacturing arrangements — the reshoring era has not reduced the importance of China trade expertise. In many respects, it has increased it. The companies that understand the full architecture of their Chinese supply relationships, and manage them with sophistication rather than rhetoric, will hold a structural advantage over those still operating under the assumption that moving a factory solves the problem.